These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24272034)

  • 21. The effect of quinagolide and cabergoline, two selective dopamine receptor type 2 agonists, in the treatment of prolactinomas.
    Di Sarno A; Landi ML; Marzullo P; Di Somma C; Pivonello R; Cerbone G; Lombardi G; Colao A
    Clin Endocrinol (Oxf); 2000 Jul; 53(1):53-60. PubMed ID: 10931080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early versus late Gamma Knife radiosurgery for Cushing's disease after prior resection: results of an international, multicenter study.
    Bunevicius A; Kano H; Lee CC; Krsek M; Nabeel AM; El-Shehaby A; Abdel Karim K; Martinez-Moreno N; Mathieu D; Lee JYK; Grills I; Kondziolka D; Martinez-Alvarez R; Reda WA; Liscak R; Su YH; Lunsford LD; Lee Vance M; Sheehan JP
    J Neurosurg; 2021 Mar; 134(3):807-815. PubMed ID: 32084634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolactinoma in a Dog.
    Cosio C; Sartori E; Garatti M; Luccardini L; Grinwis GCM; Kooistra HS; Fracassi F
    Vet Pathol; 2017 Nov; 54(6):972-976. PubMed ID: 28812531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormone levels and tumour size response to quinagolide and cabergoline in patients with prolactin-secreting and clinically non-functioning pituitary adenomas: predictive value of pituitary scintigraphy with 123I-methoxybenzamide.
    Colao A; Ferone D; Lastoria S; Cerbone G; Di Sarno A; Di Somma C; Lucci R; Lombardi G
    Clin Endocrinol (Oxf); 2000 Apr; 52(4):437-45. PubMed ID: 10762286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiosurgery: a useful first-line treatment of prolactinomas?
    Regis J; Castinetti F
    World Neurosurg; 2010 Jul; 74(1):103-4. PubMed ID: 21299992
    [No Abstract]   [Full Text] [Related]  

  • 26. Secondary Resistance to dopamine agonist after thirteen months of successful treatment in a 42 years old man.
    Laboy-Ortiz IE; Velez-Maymí S; Hernán Martínez J; Trinidad R; Mangual M; Sanchez A; Gutierrez M; Mansilla P; Rivera C; Palermo C; de Lourdes Miranda M; Brau R
    Bol Asoc Med P R; 2016; 108(1):31-36. PubMed ID: 29193928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of macroprolactinoma with cabergoline: a study of 85 patients.
    Ferrari CI; Abs R; Bevan JS; Brabant G; Ciccarelli E; Motta T; Mucci M; Muratori M; Musatti L; Verbessem G; Scanlon MF
    Clin Endocrinol (Oxf); 1997 Apr; 46(4):409-13. PubMed ID: 9196602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful Improvement of Metabolic Disorders, Including Osteopenia, by a Dopamine Agonist in a Male Patient with Macro-Prolactinoma.
    Takeno A; Yamamoto M; Okazaki K; Yamaguchi T; Sugimoto T
    Am J Case Rep; 2016 Mar; 17():160-4. PubMed ID: 26971354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cabergoline treatment in a case of macroprolactinoma after delivery.
    Falsetti L
    Acta Eur Fertil; 1995; 26(3):105-7. PubMed ID: 9098469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MASEP gamma knife radiosurgery for secretory pituitary adenomas: experience in 347 consecutive cases.
    Wan H; Chihiro O; Yuan S
    J Exp Clin Cancer Res; 2009 Mar; 28(1):36. PubMed ID: 19284583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cabergoline-induced tension pneumocephalus in a patient with giant invasive prolactinoma. Case report].
    Castro-Castro J; Torre-Eiriz JA; Pinzón-Millán A; Pastor-Zapata A
    Neurocirugia (Astur); 2011 Dec; 22(6):558-61; discussion 561. PubMed ID: 22167286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The assessment of cabergoline efficacy and tolerability in patients with pituitary prolactinoma type.
    Bolko P; Jaskuła M; Waśko R; Wołuń M; Sowiński J
    Pol Arch Med Wewn; 2003 May; 109(5):489-95. PubMed ID: 14768178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of high-dose daily cabergoline in an adolescent patient with macroprolactinoma.
    Howell DL; Wasilewski K; Mazewski CM; Hudgins RJ; Meacham LR
    J Pediatr Hematol Oncol; 2005 Jun; 27(6):326-9. PubMed ID: 15956887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A single- center experience of prolactin-producing pituitary adenomas without hyperprolactinemia: Its incidence and clinical management.
    Ogawa Y; Tominaga T
    Clin Neurol Neurosurg; 2020 Nov; 198():106123. PubMed ID: 32818756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serial 3 T magnetic resonance imaging during cabergoline treatment of macroprolactinomas.
    Kurosaki M; Kambe A; Watanabe T; Fujii S; Ogawa T
    Neurol Res; 2015 Apr; 37(4):341-6. PubMed ID: 25376133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-Term Outcome of Nonfunctioning and Hormonal Active Pituitary Adenoma After Gamma Knife Radiosurgery.
    Narayan V; Mohammed N; Bir SC; Savardekar AR; Patra DP; Bollam P; Nanda A
    World Neurosurg; 2018 Jun; 114():e824-e832. PubMed ID: 29574220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proptosis as the presenting sign of giant prolactinoma in a prepubertal boy: successful resolution of hydrocephalus by use of medical therapy.
    Cackett P; Eunson G; Bath L; Mulvihill A
    Future Oncol; 2012 Dec; 8(12):1621-6. PubMed ID: 23231524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas.
    Ono M; Miki N; Amano K; Kawamata T; Seki T; Makino R; Takano K; Izumi S; Okada Y; Hori T
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2672-9. PubMed ID: 20357175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of the Leksell gamma knife in the treatment of prolactinoma patients.
    Jezková J; Hána V; Krsek M; Weiss V; Vladyka V; Liscák R; Vymazal J; Pecen L; Marek J
    Clin Endocrinol (Oxf); 2009 May; 70(5):732-41. PubMed ID: 18710463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early versus late Gamma Knife radiosurgery following transsphenoidal surgery for nonfunctioning pituitary macroadenomas: a multicenter matched-cohort study.
    Pomeraniec IJ; Kano H; Xu Z; Nguyen B; Siddiqui ZA; Silva D; Sharma M; Radwan H; Cohen JA; Dallapiazza RF; Iorio-Morin C; Wolf A; Jane JA; Grills IS; Mathieu D; Kondziolka D; Lee CC; Wu CC; Cifarelli CP; Chytka T; Barnett GH; Lunsford LD; Sheehan JP
    J Neurosurg; 2018 Sep; 129(3):648-657. PubMed ID: 29076785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.